Bendamustine plus rituximab may have edge for treating indolent NHL, MCLJune 22, 2017Indolent Lymphoma
Lenalidomide-rituximab induces high CR rate in untreated follicular lymphomaJune 21, 2017Indolent Lymphoma
GALEN safe and effective in relapsed and refractory follicular lymphomaJune 20, 2017Indolent Lymphoma
Maintenance lenalidomide prolongs progression-free survival in DLBCLApril 30, 2017Aggressive Lymphomas
Waldenström macroglobulinemia panel advises on IgM paraproteinemic neuropathiesApril 19, 2017Indolent Lymphoma
